APOE and TREM2 are part of a large group of GWAS-identified genes associated with AD risk with glial-specific expression (microglia and astrocytes) and are related to immune response (Villegas-Llerena et al., 2016). The gene discussed is APOE; the disease is Alzheimer disease.